OA03.01 First-Line Nivolumab Monotherapy and Nivolumab plus Ipilimumab in Patients with Advanced NSCLC: Long-Term Outcomes from CheckMate 012 Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Gettinger, Scott
  • Rizvi, Naiyer
  • Chow, Laura
  • Borghaei, Hossein
  • Brahmer, Julie
  • Shepherd, Frances
  • Ready, Neal
  • Gerber, David
  • Antonia, Scott
  • Goldman, Jonathan W
  • Juergens, Rosalyn
  • Geese, William
  • Young, Tina
  • Li, Xuemei
  • Hellmann, Matthew

publication date

  • January 2017